| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 8,917 | 16,113 | 11,978 | 15,026 | | Cost of Revenue | 8,184 | 13,379 | 10,992 | 13,432 | | | Gross Profit | 733 | 2,734 | 986 | 1,594 | | | Operating Expenses | | Research Development | 4,233 | 4,457 | 5,652 | 7,964 | | Selling General and Administrative | 4,903 | 7,300 | 6,661 | 7,146 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,403) | (9,023) | (11,327) | (13,516) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 392 | (4,870) | (2,386) | (718) | | Earnings Before Interest And Taxes | (8,011) | (13,893) | (13,713) | (14,234) | | Interest Expense | 4,626 | 4,135 | 4,187 | 4,120 | | Income Before Tax | (12,637) | (18,028) | (17,900) | (18,354) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,637) | (18,028) | (17,900) | (18,354) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,637) | (18,028) | (17,900) | (18,354) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,637) | ($18,028) | ($17,900) | ($18,354) |
|
0.05% Nasdaq 
Income Statement
